

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 4.07310720 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07310720 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07310720 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07310720 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.07310720 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07310720 |
| 7 | response to peptidoglycan (GO:0032494) | 3.99917592 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.96524798 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.75965560 |
| 10 | response to muramyl dipeptide (GO:0032495) | 3.52087231 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37052852 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.26121365 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.26121365 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24265382 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.22961108 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.17304585 |
| 17 | regulation of necroptotic process (GO:0060544) | 3.10589479 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09485513 |
| 19 | negative regulation of necroptotic process (GO:0060546) | 3.09102586 |
| 20 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.08963245 |
| 21 | barbed-end actin filament capping (GO:0051016) | 2.99961251 |
| 22 | detection of other organism (GO:0098543) | 2.98349146 |
| 23 | pinocytosis (GO:0006907) | 2.92243936 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 2.90201734 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 2.88577103 |
| 26 | mannose metabolic process (GO:0006013) | 2.88252921 |
| 27 | detection of bacterium (GO:0016045) | 2.87064626 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 2.81637778 |
| 29 | regulation of cholesterol storage (GO:0010885) | 2.76061852 |
| 30 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.73254846 |
| 31 | detection of external biotic stimulus (GO:0098581) | 2.72943933 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.72306933 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 2.70543698 |
| 34 | germinal center formation (GO:0002467) | 2.69660226 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 2.69595079 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69462709 |
| 37 | response to laminar fluid shear stress (GO:0034616) | 2.67872729 |
| 38 | type I interferon signaling pathway (GO:0060337) | 2.66855490 |
| 39 | cellular response to type I interferon (GO:0071357) | 2.66855490 |
| 40 | response to type I interferon (GO:0034340) | 2.65571970 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65552701 |
| 42 | response to host immune response (GO:0052572) | 2.65552701 |
| 43 | cellular hyperosmotic response (GO:0071474) | 2.63834122 |
| 44 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58217893 |
| 45 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58200159 |
| 46 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.57562603 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 2.57378757 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 2.56462555 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.55197927 |
| 50 | protein localization to endosome (GO:0036010) | 2.55035666 |
| 51 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54736050 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.54263180 |
| 53 | urea cycle (GO:0000050) | 2.54226936 |
| 54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.53112816 |
| 55 | regulation of necrotic cell death (GO:0010939) | 2.52509027 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51486946 |
| 57 | response to host (GO:0075136) | 2.51486946 |
| 58 | response to host defenses (GO:0052200) | 2.51486946 |
| 59 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50510492 |
| 60 | regulation of monocyte differentiation (GO:0045655) | 2.49864977 |
| 61 | histone H3-K36 demethylation (GO:0070544) | 2.49039301 |
| 62 | embryonic process involved in female pregnancy (GO:0060136) | 2.48772104 |
| 63 | creatine metabolic process (GO:0006600) | 2.47841574 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.46832987 |
| 65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44069350 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43701354 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 2.43143803 |
| 68 | detection of biotic stimulus (GO:0009595) | 2.43094452 |
| 69 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.42782787 |
| 70 | negative regulation of innate immune response (GO:0045824) | 2.42525531 |
| 71 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.41945368 |
| 72 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.41945368 |
| 73 | low-density lipoprotein particle clearance (GO:0034383) | 2.41581139 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 2.41551304 |
| 75 | urea metabolic process (GO:0019627) | 2.41063675 |
| 76 | response to mercury ion (GO:0046689) | 2.40368249 |
| 77 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37228166 |
| 78 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37129682 |
| 79 | glycolipid catabolic process (GO:0019377) | 2.36759229 |
| 80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.35934278 |
| 81 | defense response to protozoan (GO:0042832) | 2.35748166 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.35744445 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.35702967 |
| 84 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.34766436 |
| 85 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.34732944 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 2.34483212 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33203401 |
| 88 | NADH metabolic process (GO:0006734) | 2.30160025 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.28756889 |
| 90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.27234330 |
| 91 | nitrogen cycle metabolic process (GO:0071941) | 2.25229464 |
| 92 | modulation by symbiont of host cellular process (GO:0044068) | 2.25035305 |
| 93 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.24605065 |
| 94 | regulation of vitamin metabolic process (GO:0030656) | 2.23881191 |
| 95 | respiratory burst (GO:0045730) | 2.23397629 |
| 96 | response to protozoan (GO:0001562) | 2.23324375 |
| 97 | endothelium development (GO:0003158) | 2.23284110 |
| 98 | negative regulation of necrotic cell death (GO:0060547) | 2.22717176 |
| 99 | positive regulation of cholesterol efflux (GO:0010875) | 2.22483209 |
| 100 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.21586391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.49458549 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.24672861 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16458705 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.94601006 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.72797991 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.61506246 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.59604933 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.56545357 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.49615956 |
| 10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.48028330 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22733472 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.20178379 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15008971 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.13718598 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13387740 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11089740 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.08556716 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08115216 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04624564 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95526046 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95478388 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90821955 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89756519 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82155734 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.77518235 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75557414 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74427582 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73919338 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70623006 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70443042 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69717742 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67983400 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65792640 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62491894 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60882766 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60482731 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59875851 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59847553 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53757789 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53259838 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52042929 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50663474 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47790098 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.45162156 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42248940 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40882596 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39865595 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37262756 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34320342 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34060002 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31698538 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30724910 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30599010 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30472294 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28836741 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27748462 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25868309 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.25227181 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23752602 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23290545 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22866623 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22718353 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22474031 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21293258 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20949727 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20662136 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19875604 |
| 68 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19412846 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18628852 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18093853 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17505089 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17351490 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17118114 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17115897 |
| 75 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.15125182 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14880027 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14137088 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13785506 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13757874 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13523360 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13267303 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11802544 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11635270 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10039296 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09543961 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09251911 |
| 87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09251911 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08503717 |
| 89 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08105678 |
| 90 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07971051 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06033509 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05577060 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04319748 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04031617 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02848759 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02364660 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01484080 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00279262 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00224480 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99823318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.76563612 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.18043491 |
| 3 | MP0009840_abnormal_foam_cell | 3.05540593 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.01961451 |
| 5 | MP0005451_abnormal_body_composition | 2.91663113 |
| 6 | MP0003724_increased_susceptibility_to | 2.88811530 |
| 7 | MP0003436_decreased_susceptibility_to | 2.74079581 |
| 8 | MP0009278_abnormal_bone_marrow | 2.59148206 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.20940464 |
| 10 | MP0000685_abnormal_immune_system | 2.17773013 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.07956371 |
| 12 | MP0008004_abnormal_stomach_pH | 2.05396447 |
| 13 | MP0002419_abnormal_innate_immunity | 2.02781602 |
| 14 | MP0008260_abnormal_autophagy | 1.99607688 |
| 15 | MP0003183_abnormal_peptide_metabolism | 1.98928128 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.98883455 |
| 17 | MP0005387_immune_system_phenotype | 1.91942454 |
| 18 | MP0001790_abnormal_immune_system | 1.91942454 |
| 19 | MP0005025_abnormal_response_to | 1.83100447 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.82295338 |
| 21 | MP0005360_urolithiasis | 1.80922666 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.76824809 |
| 23 | MP0004510_myositis | 1.74672587 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.72867640 |
| 25 | MP0001800_abnormal_humoral_immune | 1.71699659 |
| 26 | MP0009785_altered_susceptibility_to | 1.67276167 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.63448110 |
| 28 | MP0001849_ear_inflammation | 1.61819591 |
| 29 | MP0000747_muscle_weakness | 1.60936992 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.60130671 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.60130671 |
| 32 | MP0000751_myopathy | 1.57937053 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.57111181 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.55684215 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.55169355 |
| 36 | MP0002723_abnormal_immune_serum | 1.47835081 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.45735930 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.44041460 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.43205099 |
| 40 | MP0001819_abnormal_immune_cell | 1.41715778 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.40930469 |
| 42 | MP0003075_altered_response_to | 1.40122075 |
| 43 | MP0005671_abnormal_response_to | 1.39421555 |
| 44 | MP0004947_skin_inflammation | 1.39039157 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.38599209 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.36405993 |
| 47 | MP0003091_abnormal_cell_migration | 1.33076746 |
| 48 | MP0004233_abnormal_muscle_weight | 1.31638051 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.29801471 |
| 50 | MP0003828_pulmonary_edema | 1.24627431 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.22008243 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.20617609 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.20476481 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.18720755 |
| 55 | MP0000749_muscle_degeneration | 1.18365679 |
| 56 | MP0005166_decreased_susceptibility_to | 1.18289396 |
| 57 | MP0000858_altered_metastatic_potential | 1.16794730 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.16319210 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.16153538 |
| 60 | MP0004087_abnormal_muscle_fiber | 1.15787702 |
| 61 | MP0000604_amyloidosis | 1.15720403 |
| 62 | MP0008469_abnormal_protein_level | 1.12462341 |
| 63 | MP0000343_altered_response_to | 1.09808082 |
| 64 | MP0000716_abnormal_immune_system | 1.09415049 |
| 65 | MP0005330_cardiomyopathy | 1.06938526 |
| 66 | MP0002132_abnormal_respiratory_system | 1.06919962 |
| 67 | MP0004858_abnormal_nervous_system | 1.05617229 |
| 68 | MP0002398_abnormal_bone_marrow | 1.05035021 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.03192942 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.02165943 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.99283617 |
| 72 | MP0006082_CNS_inflammation | 0.99081317 |
| 73 | MP0001851_eye_inflammation | 0.97298219 |
| 74 | MP0000490_abnormal_crypts_of | 0.96534540 |
| 75 | MP0005670_abnormal_white_adipose | 0.96118387 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.95806443 |
| 77 | MP0002405_respiratory_system_inflammati | 0.94341306 |
| 78 | MP0002254_reproductive_system_inflammat | 0.94167373 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.93798932 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.93457702 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.92247014 |
| 82 | MP0001661_extended_life_span | 0.91465457 |
| 83 | MP0005365_abnormal_bile_salt | 0.91193127 |
| 84 | MP0002722_abnormal_immune_system | 0.90760458 |
| 85 | MP0002429_abnormal_blood_cell | 0.90061954 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.88652915 |
| 87 | MP0010630_abnormal_cardiac_muscle | 0.88347517 |
| 88 | MP0004130_abnormal_muscle_cell | 0.88081053 |
| 89 | MP0000689_abnormal_spleen_morphology | 0.86358751 |
| 90 | MP0005165_increased_susceptibility_to | 0.86339801 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.84937024 |
| 92 | MP0003279_aneurysm | 0.83863374 |
| 93 | MP0003646_muscle_fatigue | 0.82952486 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.81953411 |
| 95 | MP0002269_muscular_atrophy | 0.81213325 |
| 96 | MP0009764_decreased_sensitivity_to | 0.79889524 |
| 97 | MP0000249_abnormal_blood_vessel | 0.79112133 |
| 98 | MP0002971_abnormal_brown_adipose | 0.78982166 |
| 99 | MP0002796_impaired_skin_barrier | 0.78810007 |
| 100 | MP0000733_abnormal_muscle_development | 0.78570782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.04723434 |
| 2 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.96644739 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.77090051 |
| 4 | Spontaneous hematomas (HP:0007420) | 3.72840984 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.61944100 |
| 6 | Myopathic facies (HP:0002058) | 3.10704113 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.01917019 |
| 8 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99907371 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98269129 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98269129 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98269129 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.92463220 |
| 13 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91637493 |
| 14 | Colitis (HP:0002583) | 2.90117915 |
| 15 | Recurrent abscess formation (HP:0002722) | 2.86636103 |
| 16 | Myositis (HP:0100614) | 2.74445346 |
| 17 | Nemaline bodies (HP:0003798) | 2.74007165 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72421504 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.71190889 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 2.70461731 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 2.69188723 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 2.65454839 |
| 23 | Increased connective tissue (HP:0009025) | 2.64360784 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.63100935 |
| 25 | Cellulitis (HP:0100658) | 2.62612565 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.58997745 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 2.54951654 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.53784841 |
| 29 | Orchitis (HP:0100796) | 2.46715937 |
| 30 | Complement deficiency (HP:0004431) | 2.45100202 |
| 31 | Increased IgE level (HP:0003212) | 2.40362155 |
| 32 | Muscle fiber splitting (HP:0003555) | 2.39957822 |
| 33 | Thoracic kyphosis (HP:0002942) | 2.37967379 |
| 34 | Distal lower limb amyotrophy (HP:0008944) | 2.37424804 |
| 35 | Abnormality of complement system (HP:0005339) | 2.36001474 |
| 36 | Myocardial infarction (HP:0001658) | 2.35932728 |
| 37 | Distal lower limb muscle weakness (HP:0009053) | 2.35285740 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.33183639 |
| 39 | Difficulty climbing stairs (HP:0003551) | 2.29997411 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.29333142 |
| 41 | Esophageal varix (HP:0002040) | 2.28449709 |
| 42 | Purpura (HP:0000979) | 2.22679866 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.18990869 |
| 44 | Exercise-induced muscle cramps (HP:0003710) | 2.18941768 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.17382981 |
| 46 | Bulbar palsy (HP:0001283) | 2.16648584 |
| 47 | Fatigue (HP:0012378) | 2.16606029 |
| 48 | Difficulty running (HP:0009046) | 2.14939045 |
| 49 | Scapular winging (HP:0003691) | 2.11572459 |
| 50 | Stroke (HP:0001297) | 2.10282585 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.08831996 |
| 52 | Ragged-red muscle fibers (HP:0003200) | 2.05139121 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.04668561 |
| 54 | Glomerulonephritis (HP:0000099) | 2.04484330 |
| 55 | Meningitis (HP:0001287) | 2.03210493 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02988909 |
| 57 | Rimmed vacuoles (HP:0003805) | 2.01769321 |
| 58 | Spinal rigidity (HP:0003306) | 2.01713230 |
| 59 | Abnormality of the thoracic spine (HP:0100711) | 2.00166990 |
| 60 | Restrictive lung disease (HP:0002091) | 1.99043949 |
| 61 | Inflammation of the large intestine (HP:0002037) | 1.98285619 |
| 62 | Gingivitis (HP:0000230) | 1.98194065 |
| 63 | Amyloidosis (HP:0011034) | 1.97658425 |
| 64 | Optic neuritis (HP:0100653) | 1.96682137 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 1.96682137 |
| 66 | Loss of speech (HP:0002371) | 1.95658949 |
| 67 | Cerebral aneurysm (HP:0004944) | 1.95605377 |
| 68 | Visceral angiomatosis (HP:0100761) | 1.94812903 |
| 69 | Increased serum ferritin (HP:0003281) | 1.92106272 |
| 70 | Pulmonary embolism (HP:0002204) | 1.91572521 |
| 71 | Arterial thrombosis (HP:0004420) | 1.91342529 |
| 72 | Vertebral compression fractures (HP:0002953) | 1.90482755 |
| 73 | Protrusio acetabuli (HP:0003179) | 1.90481145 |
| 74 | Achilles tendon contracture (HP:0001771) | 1.89300889 |
| 75 | Polygenic inheritance (HP:0010982) | 1.89090239 |
| 76 | Hypertensive crisis (HP:0100735) | 1.88277073 |
| 77 | Hemoptysis (HP:0002105) | 1.88147556 |
| 78 | Hemangiomatosis (HP:0007461) | 1.86435621 |
| 79 | Deep venous thrombosis (HP:0002625) | 1.86024855 |
| 80 | Gastrointestinal infarctions (HP:0005244) | 1.82939720 |
| 81 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82247997 |
| 82 | Obstructive lung disease (HP:0006536) | 1.82247997 |
| 83 | Myoglobinuria (HP:0002913) | 1.82069930 |
| 84 | Back pain (HP:0003418) | 1.80747075 |
| 85 | Abnormality of the Achilles tendon (HP:0005109) | 1.80263350 |
| 86 | Muscle stiffness (HP:0003552) | 1.79320078 |
| 87 | Thin bony cortex (HP:0002753) | 1.79027653 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78427900 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78427900 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78427900 |
| 91 | Epistaxis (HP:0000421) | 1.77128302 |
| 92 | Persistence of primary teeth (HP:0006335) | 1.76676729 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76364962 |
| 94 | Recurrent fungal infections (HP:0002841) | 1.76298287 |
| 95 | Progressive muscle weakness (HP:0003323) | 1.76281296 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 1.74282197 |
| 97 | Urticaria (HP:0001025) | 1.73366721 |
| 98 | Emphysema (HP:0002097) | 1.72753246 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72749424 |
| 100 | Vasculitis (HP:0002633) | 1.72700592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.93115799 |
| 2 | ERN1 | 3.12250112 |
| 3 | TRIB3 | 2.91587874 |
| 4 | MAP4K1 | 2.64776131 |
| 5 | TTN | 2.54151670 |
| 6 | EEF2K | 2.53726405 |
| 7 | MAP2K3 | 2.44342272 |
| 8 | RIPK1 | 2.36193114 |
| 9 | SMG1 | 2.27788988 |
| 10 | OBSCN | 2.21865775 |
| 11 | MAP3K10 | 1.99599729 |
| 12 | TYK2 | 1.96955580 |
| 13 | TBK1 | 1.93824498 |
| 14 | ICK | 1.93541199 |
| 15 | FGFR4 | 1.82425131 |
| 16 | MAP3K13 | 1.72547215 |
| 17 | MAP3K14 | 1.69728575 |
| 18 | FGR | 1.65009102 |
| 19 | BLK | 1.63619403 |
| 20 | JAK3 | 1.60893694 |
| 21 | MAP3K1 | 1.53059375 |
| 22 | MAP3K3 | 1.44998282 |
| 23 | EPHB1 | 1.41934994 |
| 24 | RIPK4 | 1.40525651 |
| 25 | IRAK3 | 1.35316288 |
| 26 | MAPK12 | 1.32797405 |
| 27 | TAOK2 | 1.32696950 |
| 28 | FES | 1.31295421 |
| 29 | MAP3K11 | 1.25899233 |
| 30 | CSK | 1.22354071 |
| 31 | PDK2 | 1.20797815 |
| 32 | CDC42BPA | 1.20586717 |
| 33 | KSR2 | 1.18546553 |
| 34 | MAP3K7 | 1.11306455 |
| 35 | IRAK4 | 1.10713274 |
| 36 | MATK | 1.08631718 |
| 37 | DDR2 | 1.06497213 |
| 38 | PINK1 | 1.05234321 |
| 39 | SIK1 | 1.02228814 |
| 40 | CSF1R | 1.01266242 |
| 41 | JAK1 | 0.98251125 |
| 42 | TGFBR2 | 0.97305307 |
| 43 | ZAP70 | 0.95952373 |
| 44 | MAPK11 | 0.95036235 |
| 45 | TESK2 | 0.93117302 |
| 46 | CDK12 | 0.91135683 |
| 47 | TAOK1 | 0.90247214 |
| 48 | KDR | 0.90173665 |
| 49 | MARK3 | 0.88242317 |
| 50 | NME2 | 0.85445622 |
| 51 | MARK2 | 0.84661439 |
| 52 | NEK9 | 0.84578065 |
| 53 | RPS6KA2 | 0.83660631 |
| 54 | PDPK1 | 0.83035464 |
| 55 | PRKD2 | 0.82532025 |
| 56 | PDGFRA | 0.82351796 |
| 57 | BTK | 0.82156262 |
| 58 | RPS6KL1 | 0.80940976 |
| 59 | RPS6KC1 | 0.80940976 |
| 60 | PTK6 | 0.79108797 |
| 61 | CDK4 | 0.78870464 |
| 62 | JAK2 | 0.78197427 |
| 63 | MTOR | 0.78100619 |
| 64 | IKBKE | 0.72462003 |
| 65 | BMX | 0.71472011 |
| 66 | SIK2 | 0.70673782 |
| 67 | IKBKB | 0.67528125 |
| 68 | DYRK1B | 0.67447083 |
| 69 | EPHA3 | 0.67184107 |
| 70 | FGFR3 | 0.65801368 |
| 71 | HCK | 0.65311255 |
| 72 | MAPK7 | 0.65268977 |
| 73 | GRK6 | 0.65173838 |
| 74 | SYK | 0.62948547 |
| 75 | PAK4 | 0.62551102 |
| 76 | RPS6KA1 | 0.59034691 |
| 77 | MOS | 0.56931458 |
| 78 | MAPK4 | 0.56519089 |
| 79 | PDK1 | 0.55882385 |
| 80 | RPS6KA6 | 0.55715876 |
| 81 | PKN2 | 0.55678276 |
| 82 | LYN | 0.52502876 |
| 83 | CDK6 | 0.51972372 |
| 84 | PIM1 | 0.50272059 |
| 85 | MAP2K2 | 0.49482393 |
| 86 | PRKG2 | 0.49228067 |
| 87 | KIT | 0.47689471 |
| 88 | PRKAA2 | 0.47507535 |
| 89 | EPHB2 | 0.47497703 |
| 90 | AKT2 | 0.43571268 |
| 91 | MAP3K8 | 0.42227721 |
| 92 | ARAF | 0.41481189 |
| 93 | CCNB1 | 0.39675510 |
| 94 | MAPKAPK3 | 0.39665342 |
| 95 | CDK9 | 0.38182801 |
| 96 | LCK | 0.37999872 |
| 97 | TIE1 | 0.36569136 |
| 98 | PIM2 | 0.36443532 |
| 99 | SGK3 | 0.36163914 |
| 100 | MAP3K6 | 0.34967554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.94596237 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50307245 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16648491 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12563452 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03675591 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95195096 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75280874 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74554748 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.68099609 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63669985 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.57637470 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56775933 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53784405 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49512728 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.48736869 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46981350 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45242075 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44915722 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.40477123 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39382656 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38550782 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37084279 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35832654 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35723480 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.33586363 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31892461 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.31799880 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25973956 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.20714040 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20528943 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20128218 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18746512 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.12263090 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11495861 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11240301 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.07450696 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06961977 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00921491 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00410839 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.00163978 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.98608462 |
| 42 | Measles_Homo sapiens_hsa05162 | 0.97762791 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96856259 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96760519 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.95294062 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94780951 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.94303997 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94228973 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.93503233 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93180299 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92925943 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90107121 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85588660 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84431583 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83815205 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82130305 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81839411 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81497654 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80533093 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80373180 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.79755956 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.79452334 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.77187605 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73839231 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73633324 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.73363704 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71829421 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71504718 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70937455 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70889253 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69868165 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69800253 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.68407632 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.67796348 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67724549 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66181567 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65394111 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64323627 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63357201 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63352992 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60764322 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60693182 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58530664 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58469893 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58338437 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58312494 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56182866 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55495136 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52993727 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52207954 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52008378 |
| 92 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51843279 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48131311 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.47885566 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45408793 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45310529 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44210844 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42808351 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42745433 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.42420748 |

